Physician profile
Dora E Howard
NPI 1922049535
$4,840.69
in general payments reported to CMS, 2019-2025
37 companies · $299 in 2025
The $299 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,224 · 2022: $1,549 · 2023: $1,511 · 2024: $258 · 2025: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,983 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,983.06 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $663.91 | 2022-2023 | Precisetumor |
| Janssen Biotech, INC. | $577.49 | 2022-2024 | Erleada, Akeega, Imbruvica |
| Astrazeneca Pharmaceuticals Lp | $488.86 | 2021-2022 | |
| Glaxosmithkline, LLC. | $298.65 | 2022-2025 | Jemperli |
| Jazz Pharmaceuticals INC. | $239.03 | 2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $224.42 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $170.13 | 2021-2022 | |
| Abbvie INC. | $160.36 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $156.73 | 2021-2023 | |
| Karyopharm Therapeutics INC. | $150.02 | 2023-2024 | Xpovio |
| E.R. Squibb & Sons, L.L.C. | $148.28 | 2021-2023 | |
| Puma Biotechnology, INC. | $139.72 | 2021-2023 | |
| Genentech USA, INC. | $138.46 | 2021 | |
| Tactile Systems Technology INC | $135.96 | 2025 | Nimbl, Flexitouch Plus |
| Genzyme Corporation | $100.59 | 2023 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $100.36 | 2021 | |
| Janssen Scientific Affairs, LLC | $99.35 | 2024 | Xarelto |
| Cti Biopharma Corp. | $92.09 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $90.11 | 2022 | |
| Gilead Sciences, INC. | $86.96 | 2022 | |
| Stryker Corporation | $82.34 | 2022 | |
| Kite Pharma, INC. | $79.50 | 2023 | Yescarta |
| Pfizer INC. | $65.94 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $38.34 | 2023-2024 | Keytruda, Welireg |
| Adaptive Biotechnologies Corporation | $38.18 | 2025 | Clonoseq |
| Emd Serono, INC. | $33.23 | 2022 | |
| Adc Therapeutics America, INC. | $27.41 | 2023 | |
| Seagen INC. | $25.75 | 2022 | |
| Astellas Pharma US INC | $25.60 | 2023 | Padcev |
| Novo Nordisk INC | $25.00 | 2023 | |
| Aveo Pharmaceuticals, INC. | $24.18 | 2022 | |
| Amgen INC. | $24.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $22.36 | 2023 | |
| Daiichi Sankyo INC. | $21.86 | 2022 | |
| Beigene USA, INC. | $16.85 | 2021 | |
| G1 Therapeutics, INC. | $15.48 | 2021 | |
| Eisai INC. | $13.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dora Howard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.